 |
|
February 6, 2002
JAMA. 2002;287:655-656.
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.
Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.
CME Articles in This Issue of JAMA
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy: Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial591
Educational Objective: To learn that the effects of hormone replacement therapy on quality of life may depend on the presence of menopausal symptoms when therapy is initiated.
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men: A Randomized Controlled Trial598
Educational Objective: To compare the biochemical effects of simvastatin and diet in hypercholesterolemic men.
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000606
Educational Objective: To learn that varicella disease may be declining in areas with even moderate vaccine coverage.
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry612
Educational Objective: To learn that clinical practice guidelines may seldom be published with disclosures of financial relationships between authors and companies whose drugs were considered in the guidelines.
Long-term Efficacy of Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention618
Educational Objective: To learn that eptifibatide may improve long-term outcomes of coronary stent implantation.
Nonspecific Medication Side Effects and the Nocebo Phenomenon622
Educational Objective: To understand why some patients may experience adverse effects that do not result directly from the specific pharmacological action of the drugs they are taking.
Medical Management of Advanced Heart Failure628
Educational Objective: To review the clinical management of advanced heart failure.
After reading 3 of these articles, complete the CME Evaluation Form.
RELATED ARTICLES
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy: Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial
Mark A. Hlatky, Derek Boothroyd, Eric Vittinghoff, Penny Sharp, Mary A. Whooley, and for the HERS Research Group
JAMA. 2002;287(5):591-597.
ABSTRACT
| FULL TEXT
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men: A Randomized Controlled Trial
Antti Jula, Jukka Marniemi, Risto Huupponen, Arja Virtanen, Merja Rastas, and Tapani Rönnemaa
JAMA. 2002;287(5):598-605.
ABSTRACT
| FULL TEXT
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Jane F. Seward, Barbara M. Watson, Carol L. Peterson, Laurene Mascola, Jan W. Pelosi, John X. Zhang, Teresa J. Maupin, Gary S. Goldman, Laura J. Tabony, Kimberly G. Brodovicz, Aisha O. Jumaan, and Melinda Wharton
JAMA. 2002;287(5):606-611.
ABSTRACT
| FULL TEXT
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Niteesh K. Choudhry, Henry Thomas Stelfox, and Allan S. Detsky
JAMA. 2002;287(5):612-617.
ABSTRACT
| FULL TEXT
Long-term Efficacy of Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention
J. Conor O'Shea, Christopher E. Buller, Warren J. Cantor, A. Bleakley Chandler, Eric A. Cohen, David J. Cohen, Ian C. Gilchrist, Neal S. Kleiman, Marino Labinaz, Mina Madan, Gail E. Hafley, Robert M. Califf, Michael M. Kitt, John Strony, James E. Tcheng, and for the ESPRIT Investigators
JAMA. 2002;287(5):618-621.
ABSTRACT
| FULL TEXT
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Arthur J. Barsky, Ralph Saintfort, Malcolm P. Rogers, and Jonathan F. Borus
JAMA. 2002;287(5):622-627.
ABSTRACT
| FULL TEXT
Medical Management of Advanced Heart Failure
Anju Nohria, Eldrin Lewis, and Lynne Warner Stevenson
JAMA. 2002;287(5):628-640.
ABSTRACT
| FULL TEXT
|
